Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
101
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $115M | 0.14% |
1,212,738
-91,949
| -7% | -$8.74M |
|
102
Steris
STE
$22.6B
| $114M | 0.14% |
811,664
-56,644
| -7% | -$8.47M |
|
103
iShares Global Tech ETF
IXN
$8.74B
| $109M | 0.14% |
3,583,974
+252,306
| +8% | +$8.72M |
|
104
ScottsMiracle-Gro
SMG
$3.61B
| $108M | 0.13% |
1,057,651
-97,326
| -8% | -$10.7M |
|
105
Mercado Libre
MELI
$92.8B
| $104M | 0.13% |
212,553
+210,886
| +12,651% | +$130M |
|
106
West Pharmaceutical
WST
$24.5B
| $98.8M | 0.12% |
648,761
-75,812
| -10% | -$11.7M |
|
107
Medtronic
MDT
$110B
| $97.6M | 0.12% |
1,081,799
+918,007
| +560% | +$97.7M |
|
108
Southern Copper
SCCO
$161B
| $95.9M | 0.12% |
3,671,864
-242,648
| -6% | -$8.14M |
|
109
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| $94.6M | 0.12% |
1,736,323
-37,117
| -2% | -$1.98M |
|
110
Synaptics
SYNA
$3.99B
| $93.3M | 0.12% |
1,612,619
-22,842
| -1% | -$1.55M |
|
111
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $89.2M | 0.11% |
2,674,882
+166,764
| +7% | +$6.69M |
|
|
HRC
112
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $86.9M | 0.11% |
863,540
-55,551
| -6% | -$5.75M |
|
|
HES
113
DELISTED
Hess
HES
| $84.8M | 0.11% |
2,547,170
+93,423
| +4% | +$5.05M |
|
114
HEICO Corp
HEI
$50.8B
| $84.8M | 0.11% |
1,136,162
-94,782
| -8% | -$10.4M |
|
115
Autodesk
ADSK
$51.2B
| $82.8M | 0.1% |
530,711
+374,833
| +240% | +$68.8M |
|
116
Vanguard FTSE Europe ETF
VGK
$31.1B
| $81.4M | 0.1% |
1,879,850
+165,210
| +10% | +$8.75M |
|
117
Teledyne Technologies
TDY
$31.9B
| $79.1M | 0.1% |
266,112
-31,547
| -11% | -$10.8M |
|
118
Toro Company
TTC
$9.35B
| $79.1M | 0.1% |
1,214,881
-97,989
| -7% | -$7.44M |
|
119
Qorvo
QRVO
$8.41B
| $78.1M | 0.1% |
968,820
-48,471
| -5% | -$4.85M |
|
120
Helen of Troy
HELE
$671M
| $77.4M | 0.1% |
537,071
-38,919
| -7% | -$6.59M |
|
121
Boston Beer
SAM
$1.88B
| $76.9M | 0.1% |
209,320
-25,699
| -11% | -$9.53M |
|
122
Lumentum
LITE
$65.2B
| $75.2M | 0.09% |
1,020,275
-22,067
| -2% | -$1.74M |
|
123
Pool Corp
POOL
$7.31B
| $74.9M | 0.09% |
380,414
-19,672
| -5% | -$4.19M |
|
124
Applied Materials
AMAT
$419B
| $74.7M | 0.09% |
1,630,993
+1,626,304
| +34,683% | +$93.4M |
|
125
Bio-Rad Laboratories Class A
BIO
$9.16B
| $74M | 0.09% |
211,144
-13,499
| -6% | -$4.96M |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.